ArticlePharmacoEconomics2020

Does Cost-Effectiveness Analysis Really Need to Abandon the Incremental Cost-Effectiveness Ratio to Embrace Net Benefit?

James F O'MahonyPubMed ↗Publisher ↗

No numbers read from the abstract.